Study Findings from Stanford University Provide New Insights into Non-Small Cell Lung Cancer [Characterization of Erbb2 (Her2) Alterations In Metastatic Non-small Cell Lung Cancer and Comparison of Outcomes of Different Trastuzumab-based ...].
| Předmět: | |
|---|---|
| Zdroj: | Immunotherapy Weekly; 1/31/2023, p843-843, 1p |
| Abstrakt: | Oncology - Non-Small Cell Lung Cancer Researchers detail new data in Oncology - Non-Small Cell LungCancer. We identified 3 groupsof patients: ERBB2-mutant/EGFR-wildtype mNSCLC (n = 33),ERBB2-amplified/EGFR-wildtype mNSCLC without concurrent ERBB2 mutations(n = 6), and ERBB2-altered/EGFR-mutant mNSCLC (n = 8). [Extracted from the article] |
| Databáze: | Complementary Index |
| Externí odkaz: |
|